<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ARegulatory_due_diligence_report</id>
	<title>Definition:Regulatory due diligence report - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ARegulatory_due_diligence_report"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Regulatory_due_diligence_report&amp;action=history"/>
	<updated>2026-05-02T16:00:50Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Regulatory_due_diligence_report&amp;diff=17778&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Regulatory_due_diligence_report&amp;diff=17778&amp;oldid=prev"/>
		<updated>2026-03-15T15:38:23Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;📄 &amp;#039;&amp;#039;&amp;#039;Regulatory due diligence report&amp;#039;&amp;#039;&amp;#039; is the written deliverable that synthesizes the findings of the [[Definition:Regulatory due diligence | regulatory due diligence]] workstream in an insurance [[Definition:Mergers and acquisitions (M&amp;amp;A) | transaction]], providing the buyer and its advisors with a comprehensive assessment of the target&amp;#039;s regulatory compliance posture, [[Definition:Insurance license | licensing]] status, supervisory relationships, and the regulatory risks and approvals pathway associated with the proposed acquisition. It stands alongside the financial, actuarial, and legal due diligence reports as one of the core analytical documents on which investment and structuring decisions are based.&lt;br /&gt;
&lt;br /&gt;
⚙️ A well-constructed report typically opens with an overview of the regulatory landscape applicable to the target — identifying each [[Definition:Insurance regulator | supervisory authority]] with jurisdiction, the relevant legal frameworks (such as [[Definition:Solvency II | Solvency II]], the [[Definition:National Association of Insurance Commissioners (NAIC) | NAIC]] model laws, the Hong Kong Insurance Ordinance, or Japan&amp;#039;s Insurance Business Act), and the specific licenses and authorizations held. It then moves through a systematic analysis of compliance in areas including [[Definition:Regulatory capital | capital adequacy]], [[Definition:Corporate governance | governance]] and [[Definition:Fit and proper requirements | fit and proper]] requirements, [[Definition:Conduct risk | conduct of business]] rules, [[Definition:Anti-money laundering (AML) | AML/KYC]] obligations, and any open or historical [[Definition:Regulatory action | regulatory actions]] or investigations. A critical section addresses the [[Definition:Regulatory change of control approval | change of control approval]] process: the report maps out which filings are required, in which jurisdictions, the expected timelines and documentation demands, and any conditions or undertakings the regulator is likely to impose. Where [[Definition:Delegated underwriting authority (DUA) | delegated authority]] arrangements or [[Definition:Binding authority agreement | binding authority agreements]] are material to the target&amp;#039;s business model, the report assesses whether these survive or require re-approval post-acquisition.&lt;br /&gt;
&lt;br /&gt;
💡 The practical value of this report extends well beyond a compliance checklist. It shapes the deal&amp;#039;s timeline by identifying which [[Definition:Regulatory approval application | regulatory approvals]] sit on the critical path, informs the allocation of risk between buyer and seller in the [[Definition:Share purchase agreement (SPA) | purchase agreement]] (including specific [[Definition:Indemnity | indemnities]] for regulatory contingencies), and may reveal structural issues — such as a license that cannot be transferred to a new owner without re-application, or a supervisory requirement to maintain [[Definition:Solvency ratio | solvency margins]] above a specified level for a post-closing transition period — that directly affect deal economics. For [[Definition:Private equity | private equity]] acquirers less familiar with insurance supervision, the regulatory due diligence report often serves as the primary educational document on the supervisory constraints they are inheriting, making its clarity and depth a matter of genuine strategic importance.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Regulatory due diligence]]&lt;br /&gt;
* [[Definition:Red flag report]]&lt;br /&gt;
* [[Definition:Regulatory approval application]]&lt;br /&gt;
* [[Definition:Regulatory change of control approval]]&lt;br /&gt;
* [[Definition:Due diligence]]&lt;br /&gt;
* [[Definition:Insurance regulator]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>